Begin typing your search above and press return to search.
Volume: 22 Issue: 3 March 2024

FULL TEXT

ARTICLE
Experiences of Participation in a Study Investigating Feasibility of the Implantable Doppler Probe in Kidney Transplantation: An Embedded Qualitative Study

Abstract

Objectives: Kidney transplant survival can be improved with better graft surveillance postoperatively. In the quest to explore new technologies, we explored the feasibility of an implantable Doppler probe as a blood flow monitoring device in kidney transplant patients. This qualitative study was embedded in a feasibility trial and aimed to test the device’s clinical acceptability and obtain suggestions for the development of the intervention. Objectives included exploring the expe-riences of feasibility study participants and identifying barriers to the implementation of implantable Doppler probes in clinical practice.
Materials and Methods: We conducted semi-structured interviews containing open-ended questions with 12 feasibility study participants recruited by purposive sampling. All interviews were audio-recorded with verbatim transcription. Thematic data analysis was performed at the latent level by using an inductive approach with a previously published 6-phase guide.
Results: Three key themes emerged: (1) perceived value of the intervention in clinical practice, (2) challenges and barriers to implementation of the intervention, and (3) suggestions for the development of the intervention. Due to functional limitations and lack of research, medical professional participants revealed clinical equipoise regarding the utility of implantable Doppler probes. However, the device was well received by patient participants. Challenges included device training needs for medical professionals and educational sessions for patients. Innovative ideas for development included the insertion of a display screen, adopting disposable units to reduce overall cost, online access allowing remote monitoring, decreasing external monitoring unit size, and integrating a wireless connection with the probe to reduce signal errors and increase patient safety.
Conclusions: The clinical need for blood flow sensing technology in kidney transplants has been widely acknowledged. Implantable Doppler probes may be a beneficial adjunct in the early postoperative surveillance of kidney transplant patients. However, the device’s technical limitations are the main challenges to its acceptance in clinical practice.


Key words : Blood flow sensing technology, Kidney transplant thrombosis, Thematic analysis, Qualitative semi-structured interviews

Introduction

A kidney transplant is the best long-term renal replacement therapy for patients with end-stage renal failure.1 Despite significant advances in medical care over the past decade, about 3.5% to 5.7% of total kidney transplants are lost as a result of vascular complications.2 Arterial and venous complications contribute to 0.2% to 7.5% and 0.1% to 8.2% of total kidney graft loss, respectively.2

Patients with graft loss comprise 4% of the current haemodialysis population and 16% of patients on the transplant wait list in the United Kingdom.3 Because of the increased numbers of comorbidities, HLA sensitization, depression, and wait times for retransplant morbidity and mortality are well recognized in this patient group.4

The 30-day and 90-day mortality rates in kidney graft loss patients are 5.2% and 11.1%, respectively.5 Cardiovascular disease and infections are attributed as major causes.5 Although hemodialysis provides (at best) 10% of the normal kidney function, it is associated with a 17-fold increased risk of mortality in this patient group.6

An implantable Doppler (ID) probe is a blood flow monitoring device that is capable of delivering real-time information on vascular patency.7 The ID probe has been successfully used for microvascular monitoring in cardiovascular, plastic, and breast reconstructive surgeries.8 In a similar way, the ID probe may assist in the timely recognition of vascular complications and reduce graft loss after kidney transplant.9

According to the Medical Research Council UK guidelines, qualitative studies are endorsed to inves-tigate complex interventions as these studies can inform the decision to adopt an intervention in clinical practice, refine components of the intervention, and address research ethics.10,11 A qualitative study embedded in a feasibility trial can offer an oppor-tunity to identify the likely range of challenges and suggest solutions to mitigate them, before the conduct of a definitive large-scale trial.12

Survival after kidney transplant can be improved with better graft surveillance postoperatively.13 In the constant pursuit to explore new technologies, we previously conducted a randomized controlled trial (CONDOR study) to investigate the feasibility of ID probes as a blood flow monitoring device in kidney transplant patients.14 This qualitative study was embedded in the feasibility trial with the aim to investigate the clinical acceptability of ID probes and obtain suggestions for the development of the intervention. The objective was to explore the experiences of feasibility study participants and, by doing so, identify barriers to the implementation of ID probes in clinical practice (ie, stakeholder-related, research-specific, resources-related, cultural, and organizational barriers).

Materials and Methods

The ID probe is regularly used for the vascular moni-toring of kidney transplant patients at the Southwest Transplant Centre (SWTC), University Hospitals Plymouth NHS Trust.15 Having the ID probe in regular use at SWTC allowed us to conduct the easibility trial with an embedded qualitative study, which occurred from April 2022 to July 202314 (Figure 1).

Participant selection
Participants of the qualitative study comprised patients who underwent kidney transplant surgery with ID probe monitoring and the transplant surgeons, clinicians, and nurses involved with the postoperative patient care at the SWTC during the study duration. Selected patients were familiar with the ID probe, and healthcare professionals were knowledgeable about the functioning of the ID probe monitoring device. We used purposeful sampling to ensure the selection of information-rich participants who would provide an overall comprehensive perspective of the ID probe.16

Sample size
Participants (n = 12) consisted of 4 each of clinicians, nurses, and kidney transplant patients. The sample size was comparable to previous qualitative studies that attained theoretical saturation.17,18 All participants provided study consent. We provided participants with detailed information and a leaflet of the research process, further correspondence for member checking, and publication of findings.

Settings
All kidney transplant patients at SWTC are routinely transferred to the renal ward for postoperative management. Qualitative interviews generate the best results when conducted at timings and in settings comfortable for participants.19

Data collection
We conducted semi-structured interviews with all participants following the National Institute for Health and Care Research UK guidance on qualitative studies.20 The most effective way to explore the reflections and experiences of participants is through semi-structured interviews with open-ended questions.21 Our interviews followed a sequence starting with an introduction, an explanation of the purpose of the study, consent, and interview questions (Table 1). We encouraged participants to elaborate on their answers by using probe questions (Table 2).

The duration of the interview was 40 to 45 minutes. We conducted interviews in the renal ward, during the participants’ free time, to ensure an informal and relaxed environment without any distractions. We maintained participant privacy to allow anonymity.22 We informed participants that any quotes published would be pseudonymized and their identities kept strictly confidential.

We audio-recorded all interviews with verbatim transcription, which was subsequently deleted. We gathered field notes during the interviews to promote the richness of data.23

Ethical review
The Continuous Implantable Doppler Probe Monitoring in Renal Transplant Study (a feasibility randomized controlled study with an embedded qualitative study) was approved prospectively by the regional and national ethical committees, including Health Research Authority UK (approval reference ID 302833), North of Scotland Research Ethics Committee (approval reference ID 22/NS/0009), University of Plymouth Faculty Research Ethics and Integrity Committee (approval reference ID 3358), and University Hospitals Plymouth NHS Trust (R&D department sponsorship number 21/SUR/626.4863). The study is registered with ClinicalTrials.gov (identifier: NCT05634863).

Data analyses
Thematic analysis is a technique to identify, analyze, and interpret patterns in qualitative research.24 It allows an in-depth understanding of participants’ experiences and perspectives concerning a phenomenon.25 Limitations to thematic analysis include the time-consuming process and the dependence on the researcher’s judgment.26 To reduce the potential for interviewer bias, who had a theoretical interest in ID probe monitoring, inductive thematic analysis by data-driven identification of themes was performed.27 Moreover, as all participants had experience and knowledge of ID probes, their underlying ideas and assumptions were interpreted by latent-level content analysis.28

We followed the 6-step thematic analysis process (Figure 2), which was originally developed by Braun and Clarke.24,25 The first step was familiarization of data. We repeatedly read the collected data to identify patterns of potential interest and meaning. The second step was the generation of codes. We conducted a data-driven meaningful coding of the extracts. The third step was combining codes into themes; for this, we collated codes into broader themes. The fourth step was a review of themes; we refined the themes from codes, categories, and subthemes according to their relevance, internal homogeneity, and external heterogeneity. The fifth step was establishing the significance of themes. We identified the essence or attributes of each theme and constructed a narrative, addressing the research question. In the final step, we collected findings in the form of a concise write-up.24,25 The thematic analysis was done with NVivo software (version 12).29 We reported results under the Consolidated Criteria for Reporting Qualitative Research checklist.30

Trustworthiness of data
Some of the challenges faced in qualitative research involve the researcher’s impressions, lack of reproducibility, and generalization. Previous work has reported that the spirit of inquiry and responsiveness are more important than specific techniques to reduce bias in qualitative studies.31 Nevertheless, the demonstration of trustworthiness in qualitative research confers respectability and validity to the results. Shenton32 and Hadi and Closs33 in their studies endorsed the importance of following Guba and Lincoln’s 4-criteria strategy to ensure trustworthiness in qualitative research. The criteria and measures to ensure trustworthiness in qualitative research are described in Table 3.

Credibility
Credibility is attributed to the confidence that can be placed in the quality and integrity of the research findings.32 We applied prolonged engagement, theoretical saturation of data, and respondent validation to ensure the credibility of the results. Prolonged engagement with the participants during the interviews allowed time for an in-depth understanding of perceptions.33 We continued the recruitment of study participants until theoretical saturation of data was achieved.18 After the interviews, we contacted participants again for feedback about the emerging interpretations and noted participant reactions.34

Transferability
Transferability is the extent to which the study findings can be transferred to other settings or populations.30 Study transferability is ensured by giving an adequate description of the research processes and purposeful sampling. The qualitative research findings are transferable, as the study participants and settings are similar to any kidney transplant unit across the United Kingdom.33

Confirmability
Confirmability is the degree to which the research findings are confirmed by or agreed to by other researchers.30 Reflexivity strategies and triangulation of data collection are used to ensure rigor and value to the qualitative study. The researcher’s impressions were bracketed by the use of a reflective diary, and all research questions were formulated in a neutral format.26 The triangulation of data collection was applied by obtaining perspectives from all 3 groups of participants involved with ID probe monitoring (patients, nurses, and clinicians).16

Dependability
Dependability is the extent to which the research findings are consistent and repeatable.30 We established dependability by maintenance of an audit trail and peer review. The analysis process of this study was reviewed by 2 colleagues (clinician and transplant surgeon).35 An audit trail elaborating on all decisions by the researcher is displayed in Tables 4, 5, and 6. All themes and interpretations were supported by participants’ verbatim quotes.32 Having quotes increases the study consistency by showing a direct connection between the researcher’s interpretations and the participants’ responses.33

Results

Data analyses showed the emergence of 3 key themes: (1) perceived value of the intervention in clinical practice, (2) challenges and barriers to implementation of the intervention, and (3) suggestions for the development of the intervention. Regarding the perceived value of intervention, because of the probes’ functional limitations and lack of research in the field, the medical professionals disclosed a clinical equipoise regarding the utility of ID probes. However, the device was well received by patients. Concerning challenges and barriers, the device training needs for medical professionals and educational sessions for patients were identified, necessitating an organizational structure in the units where ID probe monitoring is not used locally. About suggestions for future development, innovative ideas comprised the insertion of a display screen, adopting disposable units to reduce overall cost, online access allowing remote monitoring, decreasing external monitoring unit size, and integrating a wireless connection with the probe to reduce signal errors and increase patient safety. A word cloud for the most frequently used words in the qualitative interviews is shown in Figure 3.

Theme 1: Perceived value of the intervention in clinical practice
Table 4 elaborates on the audit trail of theme 1. Mixed feedback was given by the participants regarding the perceived value of ID probe monitoring in kidney transplants, reflecting a clinical equipoise. Theme 1 was derived from 2 subthemes: positive and negative experiences with the monitoring device. Positive experiences with the device included benefits to the health care professionals, nurses, and the health care system. The participants felt that ID probes had the potential to improve patient safety, graft outcomes and increase financial savings to the NHS.

The Doppler signals add another layer of safety. Although I do not rely entirely on them, having it [ID probe monitoring] on the patient gives me additional security and reassurance. (clinician 1)

I was thrilled when I heard the sound [Doppler signals]. It seemed to me that all the anxiety leading up to my surgery was gone. (patient 1)

If we get good Doppler signals and the patient is otherwise stable, I feel confident to postpone the [transplant ultrasonogram] scan till the next day. (clinician 2)

If the monitoring device can [help us identify] vascular thrombosis in time, this will allow us an opportunity to improve patient outcomes and save money (and resources) on the NHS. (clinician 1)

Negative experiences with the device included difficulties encountered during the application of the device and anxiety related to false positive results.

There is not enough evidence to support the use of the [ID probe] device, and it would be more useful if we attach it to the renal vein. However, I would be happy to use it to support a research project. (clinician 3)

I don’t feel confident including additional bits to the surgery unless there is clear evidence for it. The wire can cause all sorts of problems. (surgeon 1)

I was distressed to see the nurses and clinicians worried when the (audible Doppler) signal went off. It was a stressful and draining time for me, and I thought something had gone terribly wrong. I felt so relieved after the doctor [radiologist] told me that the kidney was okay. (patient 2)

There are no long-term studies [in medical literature], and the probe might cause stenosis where it is attached. (surgeon 2)

Theme 2: Challenges and barriers to implementation of the intervention
Table 5 elaborates on the audit trail of theme 2, which highlighted participants’ difficulties and organiza-tional hurdles during the implementation of ID probes at SWTC. Two subthemes were identified. The first subtheme described difficulties encountered by health care professionals, which underlined a need for device training by health care professionals and educational sessions for the patients.

Quite a few nurses in the ward do not exactly understand how the [ID probe] device works. It would be helpful if someone goes through it in front of us. (nurse 1)
I feel nervous while attaching the probe around the renal artery, particularly in living kidney donor transplants. It is small, delicate, and takes a while. I also get worried that the probe may cause compression on the renal artery (surgeon 2)

I had been briefed about the device before my surgery. To be honest, it had slipped out of my mind. Once I heard the whooshing noise, I remembered [about the monitoring device] and was much relieved. (patient 1)

The second subtheme described the requirement of an organizational structure to support the functioning of the device in the Trust, emphasizing the need to secure administrative support and develop a pathway for the procurement and storage of the device.

It will not be easy to introduce the [ID probe monitoring] device in other transplant units. The biggest challenge will be the funding. The unit will have to allocate a safe storage area for the monitoring device when not in use. They will have to set up a mechanism by which the device is inspected and repaired. (clinician 2)
The annual transplant meeting is a nice venue to try and get consensus in the department for the use of ID probes. The device has to be financially justified by the departmental line managers. (clinician 1)

Any new transplant unit wanting to participate in the research has to get the local Trust managers, administration, and R&D department on board. (surgeon 1)

Theme 3: Suggestions for the development of the intervention
Table 6 elaborates on the audit trail of theme 3. Theme 3 described suggestions and proposals for the development of the device and consisted of 2 subthemes. The first subtheme consisted of innovative ideas for the improvement of the device in terms of insertion of a display screen, decrease in the size of the monitoring device, and introduction of financially cost-effective disposable units.

The addition of a vibrant LED screen to the device, displaying signal intensity would make interpretation of signals simpler and more understandable for us. (nurse 2)

Considering that it [ID probe] picks up electric signals, it is a very bulky device in this time and day. The size can be significantly reduced. Look at the iPhone. (nurse 1)

If the whole monitoring circuit can come in the form of a disposable unit, it will be economical and convenient to procure, store, use, and put away in the end. (nurse 3)

The second subtheme described recommended modifications that would improve patient safety, including designing a wireless connection between the probe and the monitoring device. The importance of further research to refine components of the intervention was highlighted.

There is a risk of entanglement of the monitor wire during patient shifting in the theatre and mobilization in the ward. In case of accidental disengagement of the wire, the signals disappear creating a false alarm. This can be terrifying for everyone, particularly during nighttime. (nurse 3)
Using some clever (advanced) technique like WIFI or Bluetooth between the probe and the monitoring device would remove the need for a connecting wire. This would make the device much safer and error-free. The monitor can also be connected online and readings can be accessed remotely at home (nurse 2)
There is limited information regarding the possible role of a blood flow monitoring device in kidney transplant patients. Clearly, this is an area that requires future research. We need to address these gaps in the evidence. (clinician 1)

Discussion

Qualitative studies have increasingly been incor-porated in feasibility studies to acquire a global overview of whether an intervention is ready for uptake into routine clinical practice.12 Our qualitative study was embedded in a randomized controlled trial (CONDOR study) previously conducted to assess the feasibility of blood flow sensing technology in kidney transplant patients.36 The study identified barriers and facilitators of the ID probe at an early stage, allowing improvements to be made, before the start of a pragmatic main trial. The ADNAT study10 and Project ACE11 are examples of mixed-methods studies (feasibility randomized controlled trial with embedded qualitative work) that have assessed the acceptability of interventions to stakeholders.

The study participants had mixed reactions regarding the perceived value of the intervention in clinical practice. Earlier consultations have also revealed clinical equipoise on the possible role of the ID probe as a monitoring device.37 Although the benefits of blood flow sensing technology in kidney transplant surgery have been acknowledged, a lack of information and gaps in evidence are the main reasons for apprehensions surrounding the probes’ utility.37 However, clinical equipoise is a motive for future research, as it is an essential ingredient for unbiased research with therapeutic intent.38

The clinician participants felt secure with the use of ID probes in kidney transplant patients. They described Doppler signals as reassuring, and this allowed them the comfort to request fewer color duplex ultrasonograph scans. Malik and colleagues reported reliable ID probe blood flow monitoring in a high-risk patient with a kidney transplanted directly on an iliofemoral polytetrafluoroethylene graft.39 However, the surgeons felt unsure of the device as they were concerned regarding the possible risk of renal artery constriction at the ID probe application site. Kreutz-Rodrigues and colleagues reported no adverse clinical outcomes over a 3-year follow-up of 18 patients with musculocutaneous free flaps and with retained ID probes.40 Future retrospective studies on long-term complications of retained probes are warranted.40

Similarly, there were concerns about the risk of vascular injury during probe removal. At the SWTC, ID probes have been used uneventfully in kidney transplant patients for the past 7 years,7 and no such accidents have been encountered during our study; all probes were removed safely with gentle traction on the connecting wire. Nevertheless, previous studies have reported bleeding from arterial anastomosis and pedicle laceration with resultant graft loss following probe extraction.41,42 Because the probe is not under direct vision during its detachment from the renal artery, any accidental bleeding could be catastrophic in kidney transplant patients.8

The ID probe was well received by the patient participants. No issues regarding recruitment, randomization, and follow-up were reported. The patients understood the importance of research and were keen to participate in the study. Earlier work conducted on the ID probe also revealed enthusiastic patient participation.37 Patients valued participating in their postoperative care, and the probe did not cause any discomfort or hindrance to their mobility.43 The clinician participants deemed the outcome measures selected for the study as appropriate, routinely measured in clinical practice, and easily comparable to inform clinical decision-making.

Individual-specific and organizational challenges to the implementation of ID probes in clinical practice were identified. Requirements for device training for health care professionals and educational sessions for patients were proposed to reduce professional anxiety and apprehensions, respectively. In their qualitative study, Macurik and colleagues emphasized the importance of training professionals and educating patients in intervention plans.44 No problems with intervention adherence at the SWTC were reported. Because all of the participants were known to the researcher, to avoid social desirability bias, his viewpoint on the device was not disclosed.37 To avoid problems of adherence at other participating centers, the motivation of clinicians and prolonged engagement with patients are recommended as key considerations to inspire retention.10 Likewise, other centers would have to develop a device-related organi-zational structure and pathways for procurement, storage, and maintenance.

The interviews revealed innovative ideas for the improvement of the ID monitoring device. The nurses suggested the insertion of a vibrant display screen and a decrease in the size of the monitoring device. The visual presentation of the signals would assist signal interpretation and reduce nurses’ learning curves for the device. It would also allow the functioning of the monitoring device in silent mode while patients are resting. Designing small disposable units would be convenient for patients and could reduce the overall cost of procurement, storage, and maintainance.45

The clinicians proposed modifications to the device to address its technical limitations and increase patient safety. The probe is attached to the external monitoring device with a delicate connecting wire.9 This wire is sensitive to traction and easily dislodged, particularly during patient movement. An inadvertent wire detachment leads to false positive cases (ie, cessation of signals, despite normal blood flow in the vessels).15 Negative surgical reexplorations in false positive cases resulting from accidental wire disentanglements have been reported.8 A second shortcoming of the ID probe is its capacity to provide reliable patency information of only the vessel to which it is attached. In kidney transplants, the ID probe is attached to the renal artery, so it offers direct blood flow assessment of the renal artery14; because the probe cannot be attached to thin-walled renal veins, it is unable to provide direct information on renal vein patency.15 These drawbacks can be thwarted by designing a wireless connection between the probe and the monitoring device. Developing a link through Bluetooth or WIFI systems could enable probes to be attached to renal veins, increasing the accuracy of venous return information and reducing false positive cases resulting from inadvertent wire detachments.

The essence of the interviews demonstrated that the participating groups appreciated the benefits of a blood flow monitoring device in the postoperative care of kidney transplant patients. Previous studies evaluating the merits of ID probes are in agreement, that thrombotic graft loss can only be reduced with timely diagnosis and prompt surgical intervention.37,39 However, the value of an ID probe as a blood flow monitoring device, its role in the prevention of graft loss, and its acceptability to stakeholders can be substantially improved by refining the components of the intervention. An ID probe may be used as a beneficial adjunct for vascular monitoring of kidney transplant patients, alongside the traditional clinical assessment techniques and color duplex ultrasonography.43

There was complete consensus among all participant groups for the need for continuing research to improve graft outcomes. A pragmatic large-scale controlled study is recommended to evaluate the effectiveness of ID probes in clinical settings.46

Conclusions

There is a clinical requirement for the implemen-tation of blood flow sensing technology in kidney transplantation. The use of ID probes may be a beneficial adjunct in the early postoperative surveillance of kidney transplant patients. However, the device’s technical limitations are the main challenges to its acceptance in clinical practice.


References:

  1. Ietto G, Iori V, Inversini D, et al. Indocyanine green angiography for quality assessment of renal graft before transplantation: a pilot study. Exp Clin Transplant. 2023;21(2):110-115. doi:10.6002/ect.2022.0339
    CrossRef - PubMed
  2. Keller AK, Jorgensen TM, Jespersen B. Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. J Transplant. 2012;2012:793461. doi:10.1155/2012/793461
    CrossRef - PubMed
  3. UK Renal Registry. UK Renal Registry 24th Annual Report. Data to December 12, 2020. 2022. https://ukkidney.org/audit-research/annual-report
    CrossRef - PubMed
  4. Kabani R, Quinn RR, Palmer S, et al. Risk of death following kidney allograft failure: a systematic review and meta-analysis of cohort studies. Nephrol Dial Transplant. 2014;29(9):1778-1786. doi:10.1093/ndt/gfu205
    CrossRef - PubMed
  5. Bisigniano L, Laham G, Giordani MC, et al. Reduced survival in patients who return to dialysis after kidney allograft failure. Clin Transplant. 2020;34(9):e14014. doi:10.1111/ctr.14014
    CrossRef - PubMed
  6. Kramer A, Pippias M, Noordzij M, et al. The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary. Clin Kidney J. 2018;11(1):108-122. doi:10.1093/ckj/sfx149
    CrossRef - PubMed
  7. Malik MS, Akoh J, Aroori S, Latour JM. Implantable Doppler probe as a vascular monitoring device in kidney transplant patients: investigation of use at a single center. Exp Clin Transplant. 2022;20(4):355-361. doi:10.6002/ect.2021.0500
    CrossRef - PubMed
  8. Malik MS, Akoh JA, Houlberg K. The use of the Implantable Doppler probe as a blood flow monitoring device in clinical settings: a narrative review of the evidence. Exp Clin Transplant. 2023;21(2):83-92. doi:10.6002/ect.2022.0349
    CrossRef - PubMed
  9. Crane J, Hakim N. The use of an implantable Doppler flow probe in kidney transplantation: first report in the literature. Exp Clin Transplant. 2011;9(2):118-120.
    CrossRef - PubMed
  10. Cooper H, Lancaster GA, Gichuru P, Peak M. A mixed methods study to evaluate the feasibility of using the Adolescent Diabetes Needs Assessment Tool App in paediatric diabetes care in preparation for a longitudinal cohort study. Pilot Feasibility Stud. 2017:6:4:13. doi:10.1186/s40814-017-0164-5
    CrossRef - PubMed
  11. Fiallo-Scharer R, Palta M, Chewning BA, Wysocki T, Wetterneck TB, Cox ED. Design and baseline data from a PCORI-funded randomized controlled trial of family-centered tailoring of diabetes self-management resources. Contemp Clin Trials. 2017;58:58-65. doi:10.1016/j.cct.2017.04.007
    CrossRef - PubMed
  12. National Institute for Health and Care. Additional guidance for applicants including a clinical trial, pilot study or feasibility as part of a personal award application. Accessed May 26, 2023. https://www.nihr.ac.uk/documents/additional-guidance-for-applicants-including-a-clinical-trial-pilot-study-or-feasibility-as-part-of-a-personal-award-application/11702
    CrossRef - PubMed
  13. Hakim DN, Nader MA, Sood A, Kandilis A, Hakim NS. Rescue of transplanted kidney thanks to an implantable Doppler probe: is this the future? Exp Clin Transplant. 2016;14(4):454-455. Doi:10.6002/ect.2014.0135
    CrossRef - PubMed
  14. Malik MS, Akoh JA, Houlberg K. A study protocol exploring the role of an implantable doppler probe in kidney transplantation: a feasibility randomized controlled trial with an embedded qualitative study. Exp Clin Transplant. 2023;21(6):493-503. Doi:10.6002/ect.2023.0031
    CrossRef - PubMed
  15. Malik MS, Saif I, Akoh J. Are signals from implantable Doppler probes always accurate for prediction of blood flow in kidney transplant? Exp Clin Transplant. 2023;21(1):52-54. Doi:10.6002/ect.2022.0318
    CrossRef - PubMed
  16. Valerio MA, Rodriguez N, Winkler P, et al. Comparing two sampling methods to engage hard-to-reach communities in research priority setting. BMC Med Res Methodol. 2016;16(1):146. Doi:10.1186/s12874-016-0242-z
    CrossRef - PubMed
  17. Lovegrove CJ, Bannigan K, Cheeseman D, Latour JM. The involvement of people with Parkinson’s in designing a study of the lived experience of anxiety. Br J Occup Ther. 2017;80(8):494-501. Doi:10.1177/0308022617700654
    CrossRef - PubMed
  18. Boote J, Baird W, Beecroft C. Public involvement at the design stage of primary health research: a narrative review of case examples. Health Policy. 2010;95(1):10-23. Doi:10.1016/j.healthpol.2009.11.007
    CrossRef - PubMed
  19. Price A, Albarqouni L, Kirkpatrick J, et al. Patient and public involvement in the design of clinical trials: an overview of systematic reviews. J Eval Clin Pract. 2018;24(1):240-253. Doi:10.1111/jep.12805
    CrossRef - PubMed
  20. Graham T, Alderson P, Stokes T. Managing conflicts of interest in the UK National Institute for Health and Care Excellence (NICE) clinical guidelines programme: qualitative study. PloS One. 2015;10(3):e0122313. Doi:10.1371/journal.pone.0122313
    CrossRef - PubMed
  21. Trillingsgaard C, Nielsen BK, Hjøllund NH, Lomborg K. Use of patient-reported outcomes in outpatient settings as a means of patient involvement and self-management support–a qualitative study of the patient perspective. Eur J Person Centered Healthcare. 2016;4(2):359-367.
    CrossRef - PubMed
  22. National Institute for Health and Care Research. Involve patients. Accessed September 15, 2022. https://www.nihr.ac.uk/health-and-care-professionals/engagement-and-participation-in-research/involve-patients.htm
    CrossRef - PubMed
  23. Phillippi J, Lauderdale J. A guide to field notes for qualitative research: context and conversation. Qual Health Res. 2018;28(3):381-388. doi:10.1177/1049732317697102
    CrossRef - PubMed
  24. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77-101. doi:10.1191/1478088706qp063oa
    CrossRef - PubMed
  25. Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019;11(4):589-597. doi:10.1080/2159676X.2019.1628806
    CrossRef - PubMed
  26. Ortlipp M. Keeping and using reflective journals in the qualitative research process. Qual Rep. 2008;13(4):695-705. doi:10.46743/2160-3715/2008.1579
    CrossRef - PubMed
  27. Monsen KA, Westra BL, Yu F, Ramadoss VK, Kerr MJ. Data management for intervention effectiveness research: comparing deductive and inductive approaches. Res Nurs Health. 2009;32(6):647-656. doi:10.1002/nur.20354
    CrossRef - PubMed
  28. Maguire M, Delahunt B. Doing a thematic analysis: a practical, step-by-step guide for learning and teaching scholars. All Ireland J Higher Educ. 2017;9(3).
    CrossRef - PubMed
  29. QSR International. NVivo 12. March 2020. https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home
    CrossRef - PubMed
  30. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-357. doi:10.1093/intqhc/mzm042
    CrossRef - PubMed
  31. Morrow SL. Quality and trustworthiness in qualitative research in counseling psychology. J Couns Psychol. 2005;52(2):250-260. doi:1037/0022-0167.52.2.250
    CrossRef - PubMed
  32. Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Educ Inform. 2004;22(2):63-75. doi:10.3233/EFI-2004-22201
    CrossRef - PubMed
  33. Hadi MA, Jose Closs S. Ensuring rigour and trustworthiness of qualitative research in clinical pharmacy. Int J Clin Pharm. 2016;38(3):641-646. doi:10.1007/s11096-015-0237-6
    CrossRef - PubMed
  34. Torrance H. Triangulation, respondent validation, and democratic participation in mixed methods research. J Mixed Methods Res. 2012;6(2):111-123. doi:10.1177/1558689812437185
    CrossRef - PubMed
  35. Bradley L, Thouësny S. Students’ collaborative peer reviewing in an online writing environment. Themes Sci Technol Educ. 2017;10(2):69-83.
    CrossRef - PubMed
  36. Shahzar Malik, Kris Houlberg, Jacob A Akoh. Exploring the role of an implantable Doppler probe as a blood flow monitoring device in kidney transplantation: a feasibility randomized controlled trial. Exp Clin Transplant. 2023; 21(11):860-867. DOI: 0.6002/ect.2023.0272.
    CrossRef - PubMed
  37. Malik MS, Abideen ZU, Akoh JA, Houlberg K. Exploring views and expectations of clinicians, nurses, and kidney transplant recipients regarding protocol development of a study to investigate feasibility of the implantable Doppler probe in kidney transplantation: patient-public involvement consultations. Exp Clin Transplant. 2023;21(4):307-316. doi:10.6002/ect.2023.0025
    CrossRef - PubMed
  38. Cook C, Sheets C. Clinical equipoise and personal equipoise: two necessary ingredients for reducing bias in manual therapy trials. J Man Manip Ther. 2011;19(1):55-57. doi:10.1179/106698111X12899036752014
    CrossRef - PubMed
  39. Malik MS, Akoh JA, Houlberg K, Barwell J, Powell R. Iliofemoral polytetrafluoroethylene graft interposition: a rescue procedure in external iliac artery dissection to restore lower limb revascularization and salvage kidney transplant. Exp Clin Transplant. 2023;21(5):467-470. doi:10.6002/ect.2023.0062
    CrossRef - PubMed
  40. Kreutz-Rodrigues L, Gibreel W, Carlsen BT, Frick MA, Mardini S, Bakri K. Clinical and radiological safety of retained implantable Doppler devices used for free flap monitoring. Plast Surg (Oakv). 2022;30(1):20-24. doi:10.1177/22925503211006537
    CrossRef - PubMed
  41. Anctil V, Brisebois S, Fortier PH. Free Flap Anastomosis leak after implantable Doppler removal. OTO Open. 2017;1(1):2473974X17697057. doi:10.1177/2473974X17697057
    CrossRef - PubMed
  42. Hayler R, Low TH, Fung K, Nichols AC, MacNeil SD, Yoo J. Implantable Doppler ultrasound monitoring in head and neck free flaps: balancing the pros and cons. Laryngoscope. 2021;131(6):E1854-E1859. doi:10.1002/lary.29247
    CrossRef - PubMed
  43. Malik MS, Akoh J, Houlberg K. Exploring the risk factors and preventable measures for early graft loss in kidney transplantation: a single-center analysis in the southwest of the United Kingdom. Exp Clin Transplant. 2023;21(8):639-644. doi:10.6002/ect.2023.0099
    CrossRef - PubMed
  44. Macurik KM, O’kane NP, Malanga P, Reid DH. Video training of support staff in intervention plans for challenging behavior: comparison with live training. Behav Intervent. 2008;23(3):143-163. doi:10.1002/bin.261
    CrossRef - PubMed

  45. Oliveira M, Zancul E, Fleury AL. Design thinking as an approach for innovation in healthcare: systematic review and research avenues. BMJ Innovations. 2021;7(2):491-498.
    CrossRef - PubMed
  46. Malik MS, Akoh JA, Houlberg K. The effectiveness of implantable Doppler probe versus standard clinical care in the postoperative vascular surveillance of kidney transplant patients: a systematic review. PROSPERO 2023 CRD42023455444. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023455444
    CrossRef - PubMed


Volume : 22
Issue : 3
Pages : 189 - 199
DOI : 10.6002/ect.2023.0273


PDF VIEW [1180] KB.
FULL PDF VIEW

From the Southwest Transplant Centre, University Hospitals Plymouth National Health Service Trust, United Kingdom
Acknowledgements: The authors have not received any funding or grants in support of the presented research or for the preparation of this work and have no declarations of potential conflicts of interest.
Corresponding author: Muhammad Shahzar Malik, Southwest Transplant Centre, Derriford Hospital, University Hospitals Plymouth NHS Trust, PL6 8DH, UK
E-mail: shahzar.malik@nhs.net